Developers celebrate gains for advances with radiopharmaceuticals while regulators and isotope suppliers work to keep up.
KEARNEY — The University of Nebraska at Kearney announced students who earned a place on the dean’s list for the fall 2024 semester. Students who are on the dean’s list must have completed ...
Valley View High School Principal Lawrence Pegula announced the names of the students who qualified for the honor roll for the first marking period of the 2024-2025 school year, as follows.
The results, photos and official rankings from the Groundhog Run 2025 in Kansas City (Missouri, USA). The result lists from Groundhog Run on February 2, 2025. On this page you can also find the ...
KEARNEY — Junior Lily Novacek broke the University of Nebraska at Kearney weight-throw record Friday at the Charlie Foster Classic in Cushing Coliseum. Novacek set a personal best of 59 feet ...
The University of Nebraska at Kearney track and field team won 10 events Saturday at the Concordia Classic in Seward. For a second straight week junior Lily Novacek broke her personal best in the ...
Central Community College has announced the names of full-time students who earned spots on the President’s and Dean’s honor ...
Over the past six months, Eli Lilly (NYSE: LLY) has underperformed broader equities. While that's not much of an issue in the grand scheme of things, it is still a bit surprising, since the ...
7h
Investor's Business Daily on MSNEli Lilly Jumps, Reversing Its Weight-Loss Setback, On A Strong 2025 OutlookEli Lilly stock reversed higher Thursday on its upbeat outlook despite lighter-than-expected fourth-quarter sales of its well-known weight-loss and diabetes drugs.Please watch the video at ...
Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...
Eli Lilly's GLP-1 market dominance, supported by superior efficacy and strong manufacturing investments, positions it as a leader alongside Novo Nordisk, with forecasted revenue growth to $75B by ...
In Eli Lilly's most recent quarter, which ended on Sept. 30, 2024, it grew its sales by 20% to $11.4 billion. It also had multiple products that generated over $1 billion in revenue, including its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results